Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Colonic Neoplasms × avelumab × Clear all

Phase

Status

Unknown 1 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Neoplasm Metastasis 6 Colorectal Neoplasms 6 Carcinoma, Transitional Cell 6 Urinary Bladder Neoplasms 5 Ovarian Neoplasms 5 Carcinoma, Renal Cell 4 Recurrence 3 Glioblastoma 3 Carcinoma, Neuroendocrine 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neuroendocrine Tumors 2 Kidney Neoplasms 2 Kidney Diseases 2 Glioma 2 Fallopian Tube Neoplasms 2 Carcinoma, Merkel Cell 2 Uterine Cervical Neoplasms 1 Urothelial Cancer 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1 Testicular Diseases 1 Sezary Syndrome 1 Sarcoma 1 Rectal Neoplasms 1

Interventions

Fluorouracil 105 Leucovorin 99 Oxaliplatin 85 Irinotecan 75 Bevacizumab 44 Cetuximab 34 Capecitabine 33 Folfox protocol 27 Panitumumab 17 Colonoscopy 15 Chemotherapy, Adjuvant 15 Floxuridine 14 Early Intervention, Educational 12 Erlotinib Hydrochloride 11 Surveys and Questionnaires 10 IFL protocol 10 Immunohistochemistry 9 Counseling 9 Methods 8 Gemcitabine 8 Exercise 8 Dexamethasone 8 Psychiatric Rehabilitation 7 Celecoxib 7 Blood Specimen Collection 7 sargramostim 6 Radiotherapy 6 Nivolumab 6 Melphalan 6 Gene Expression Profiling 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03854799 2023-10-19

AVANA

Gruppo Oncologico del Nord-Ovest

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡